Interleukin (IL)‐17‐producing pathogenic T lymphocytes co‐express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study
暂无分享,去创建一个
R. Giacomelli | R. Gerli | E. Bartoloni | A. Alunno | P. Di Benedetto | F. Carubbi | P. Cipriani | O. Bistoni | S. Caterbi